glp-1 gip dual agonist GIPR/GLP-1R therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application glp 1 and gip glp

Study medications, GLP-1 RAs, dipeptidyl peptidase 4 inhibitors and pramlintide were not allowed as rescue medications

Eli Lilly & Co

According to the Cleveland Clinic, GLP-1 receptor agonists like Ozempic can stimulate insulin release, suppress the release of glucagon, slow digestion, and increase how full you feel after eating

Use bacteriostatic water (not sterile water) to extend solution stability after reconstitution

Intensified, multifactorial treatment to therapeutic goals (targeting glycemic control, blood pressure, lipid levels, and renal function) has been associated with a reduction in cardiovascular and microvascular complications (27)

Use in type 1 diabetes The ADJUNCT ONE trial (Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes), 55 the ADJUNCT TWO trial, 56 and a large meta-analysis 57 found reductions in hemoglobin A1c, body weight, and total daily dose of insulin, but also highlighted an increase in hyperglycemia with ketosis in patients with type 1 diabetes mellitus receiving liraglutide or exenatide in combination with insulin